Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 1,369-1,380 of 10,592
Device study icon
RecruitingNCT06400810

Proximal Risk for Suicide in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityDeviceA study involving a tool, app, wearable, test, or medical device.From 13 Years to 17 Years
Countries
United States
Sponsor
Oregon Health and Science University
Condition
Suicidality
Drug study icon
RecruitingNCT06796062

Psilocybin for Addiction (OUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Addiction
Drug study icon
RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
DepressionDrugFrom 18 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
Drug study icon
RecruitingNCT06899594

Psilocybin for Methamphetamine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 25 Years to 65 Years
Countries
United States
Sponsor
Kevin Murnane
Condition
Addiction
Drug study icon
RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
DepressionDrugFrom 21 Years to 80 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
Drug study icon
RecruitingNCT06810310

Psilocybin on Brain Mechanisms of Motivation in OUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Addiction
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.

In United States
DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Drug study icon
RecruitingNCT06455293

Psilocybin Therapy for Depression in Parkinson's Disease

This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
DepressionDrugFrom 40 Years to 80 Years
Countries
United States
Sponsor
Joshua Woolley, MD, PhD
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.